Combination of interferon alfa 2b and ribavirin in liver transplant recipients with histologic recurrent hepatitis C

被引：0
|
作者：
Firpi, RJ [1 ]
Nelson, DR [1 ]
Soldevila, C [1 ]
Abdelmalek, MF [1 ]
Reed, A [1 ]
Hemming, A [1 ]
Howard, R [1 ]
Van der Werk, W [1 ]
Lauwers, G [1 ]
Davis, GL [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
495
引用
收藏
页码：A93 / A93
页数：1
相关论文
共 50 条
  • [21] Interferon α 2B and ribavirin in severe recurrent cholestatic hepatitis C
    Ong, JP
    Younossi, ZM
    Gramlich, T
    Goodman, Z
    Mayes, J
    Sarbah, S
    Yen-Lieberman, B
    TRANSPLANTATION, 2001, 71 (10) : 1486 - 1488
  • [22] Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients
    Kornberg, A
    Hommann, M
    Tannapfel, A
    Wagner, T
    Grube, T
    Schotte, U
    Voigt, R
    Scheele, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (04) : 350 - 355
  • [23] Ribavirin monotherapy in liver transplant recipients with recurrent hepatitis C
    Lionetti, R
    Tisone, G
    Di Paolo, D
    Zazza, S
    Casarelli, F
    Manzia, TM
    Petrolati, A
    Cepparalo, M
    Angelico, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 39 - 40
  • [24] Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin
    Lavezzo, B
    Franchello, A
    Smedile, A
    David, E
    Barbui, A
    Torrani, M
    Ottobrelli, A
    Zamboni, F
    Fadda, M
    Bobbio, A
    Salizzoni, M
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2002, 37 (02) : 247 - 252
  • [25] Interferon alfa 2B and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon monotherapy.
    Hajjar, B
    Galica, M
    Weisz, K
    Salen, G
    Dieterich, DT
    HEPATOLOGY, 1999, 30 (04) : 624A - 624A
  • [26] Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin
    Arrigo, Richard
    Samanta, Arun
    Griffith, Shanthini
    Parekh, Ravish M.
    Korogodsky, Maria
    Rao, Kiran V.
    Fisher, Adrian
    Wilson, Dorian
    Klein, Kenneth M.
    Koneru, Baburao
    GASTROENTEROLOGY, 2011, 140 (05) : S459 - S459
  • [27] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [28] Preemptive therapy with combination pegylated interferon and ribavirin in liver transplant recipients with hepatitis C virus
    Neff, GW
    O'Brien, CB
    Safdar, K
    Ruiz, P
    Bejarano, P
    Montalbano, M
    Schiff, ER
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
  • [29] Hepatitis C Genotype 1 Treatment Response And Outcomes Utilizing Combination Therapy With Telaprevir, Pegylated Interferon Alfa 2a And Ribavirin In Liver Transplant Recipients With Recurrent Cirrhosis
    Bhamidimarri, Kalyan R.
    Peyton, Adam
    Aye, Lydia
    Copado, Violet
    Junaidi, Omer
    Levy, Cynthia
    Martin, Paul
    Rudraraju, Madhavi
    HEPATOLOGY, 2013, 58 : 1164A - 1164A
  • [30] Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
    Bizollon, T
    Palazzo, U
    Ducerf, C
    Chevallier, M
    Elliott, M
    Baulieux, J
    Pouyet, M
    Trepo, C
    HEPATOLOGY, 1997, 26 (02) : 500 - 504
12345